Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle

FASEB Journal

Volumn 19, Issue 1, 2005, Pages 43-52

  Garnier, Anne ^a   Fortin, Dominique ^a   Zoll, Joffrey ^b   N'Guessan, Benoit ^b   Mettauer, Bertrand ^a   Lampert, Eliane ^b   Veksler, Vladimir ^a   Ventura Clapier, Renée ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Endurance training; Heart failure; Mitochondrial biogenesis; Mitochondrial function

Indexed keywords

CALCINEURIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR IIA;

ADULT; ARTICLE; BIOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; EXERCISE; EXERCISE TEST; GENE EXPRESSION; GENE FUSION; HEART FAILURE; HUMAN; HUMAN TISSUE; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASTUS LATERALIS MUSCLE;

VENTURA;

EID: 11244315114     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2173com     Document Type: Article

References (48)

1. Holloszy, J. O., and Coyle, E. F. (1984) Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J. Appl. Physiol. 56, 831-838
2. Hoppeler, H., and Fluck, M. (2003) Plasticity of skeletal muscle mitochondria: structure and function. Med. Sci. Sports Exerc. 35, 95-104
3. Tonkonogi, M., Harris, B., and Sahlin, K. (1998) Mitochondrial oxidative function in human saponin-skinned muscle fibres: effects of prolonged exercise. J. Physiol. 510, 279-286
4. Zoll, J., Sanchez, H., N'Guessan, B., Ribera, F., Lampert, E., Bigard, X., Serrurier, B., Fortin, D., Geny, B., Veksler, V., Ventura-Clapier, R., and Mettauer, B. (2002) Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J. Physiol. (London) 543, 191-200
5. Drexler, H., Riede, U., Munzel, T., Konig, H., Funke, E., and Jusu, H. (1992) Alterations of skeletal muscle in chronic heart failure. Circulation 85, 1751-1759
6. Poole-Wilson, P. A., and Ferrari, R. (1996) Role of skeletal muscle in the syndrome of chronic heart failure. J. Mol. Cell. Cardiol. 28, 2275-2285
7. Mettauer, B., Zoll, J., Sanchez, H., Lampert, E., Ribera, F., Veksler, V., Bigard, X., Mateo, P., Epailly, E., Lonsdorfer, J., and Ventura-Clapier, R. (2001) Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J. Am. Coll. Cardiol. 38, 947-954
8. Williams, A. D., Selig, S., Hare, D. L., Hayes, A., Krum, H., Patterson, J., Geerling, R. H., Toia, D., and Carey, M. F. (2004) Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J. Card. Fail. 10, 141-148
9. Adhihetty, P. J., Irrcher, I., Joseph, A. M., Ljubicic, V., and Hood, D. A. (2003) Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp. Physiol. 88, 99-107
10. Scarpulla, R. C. (2002) Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286, 81-89
11. Knutti, D., and Kralli, A. (2001) PGC-1, a versatile coactivator. Trends Endocrinol. Metab. 12, 360-365
12. Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., Wu, W., Bassel-Duby, R., and Williams, R. S. (1998) A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12, 2499-2509
13. Olson, E. N., and Williams, R. S. (2000) Calcineurin signaling and muscle remodeling. Cell 101, 689-692
14. Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) Transcriptional coactivator PGC-1alpha drives the formation of slow-twitch muscle fibres. Nature (London) 418, 797-801
15. Handschin, C., Rhee, J., Lin, J., Tarr, P. T., and Spiegelman, B. M. (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} expression in muscle. Proc. Natl. Acad. Sci. USA 100, 7111-7116
16. Norrbom, J., Sundberg, C. J., Ameln, H., Kraus, W. E., Jansson, E., and Gustafsson, T. (2004) PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J. Appl. Physiol. 96, 189-194
17. Bengtsson, J., Gustafsson, T., Widegren, U., Jansson, E., and Sundberg, C. J. (2001) Mitochondrial transcription factor A and respiratory complex IV increase in response to exercise training in humans. Pfluegers Arch. 443, 61-66
18. Tunstall, R. J., Mehan, K. A., Wadley, G. D., Collier, G. R., Bonen, A., Hargreaves, M., and Cameron-Smith, D. (2002) Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am. J. Physiol. 283, E66-E72
19. Russell, A. P., Feilchenfeldt, J., Schreiber, S., Praz, M., Crettenand, A., Gobelet, C., Meier, C. A., Bell, D. R., Kralli, A., Giacobino, J. P., et al. (2003) Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 52, 2874-2881
20. Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N., Rizza, R. A., Coenen Schimke, J. M., and Nair, K. S. (2003) Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52, 1888-1896
21. Pilegaard, H., Saltin, B., and Neufer, P. D. (2003) Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J. Physiol. 546, 851-858
22. Ventura-Clapier, R., Garnier, A., and Veksler, V. (2004) Energy metabolism in heart failure. J. Physiol. 555, 1-13
23. Garnier, A., Fortin, D., Delomenie, C., Momken, I., Veksler, V., and Ventura-Clapier, R. (2003) Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551, 491-501
24. Bota, D. A., and Davies, K. J. A. (2001) Protein degradation in mitochondria: implication for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders. Mitochondrion 1, 33-49
25. Luciakova, K., Sokolikova, B., Chloupkova, M., and Nelson, B. D. (1999) Enhanced mitochondrial biogenesis is associated with increased expression of the mitochondrial ATP-dependent Lon protease. FEBS Lett. 444, 186-188
26. Yaffe, M. P. (1999) The machinery of mitochondrial inheritance and behavior. Science 283, 1493-1497
27. Rojo, M., Legros, F., Chateau, D., and Lombes, A. (2002) Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 115, 1663-1674
28. Santel, A., Frank, S., Gaume, B., Herrler, M., Youle, R. J., and Fuller, M. T. (2003) Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J. Cell Sci. 116, 2763-2774
29. Pitts, K. R., Yoon, Y., Krueger, E. W., and McNiven, M. A. (1999) The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells. Mol. Biol. Cell 10, 4403-4417
30. Smirnova, E., Griparic, L., Shurland, D. L., and van der Bliek, A. M. (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 12, 2245-2256
31. Legros, F., Lombes, A., Frachon, P., and Rojo, M. (2002) Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol. Biol. Cell 13, 4343-4354
32. De Sousa, E., Veksler, V., Bigard, X., Mateo, P., and Ventura-Clapier, R. (2000) Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102, 1847-1853
33. Yang, J., Rothermel, B., Vega, R. B., Frey, N., McKinsey, T. A., Olson, E. N., Bassel-Duby, R., and Williams, R. S. (2000) Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. 87, E61-E68
34. Larrouy, D., Vidal, H., Andreelli, F., Laville, M., and Langin, D. (1999) Cloning and mRNA tissue distribution of human PPAR-gamma coactivator-1. Int. J. Obes. Relat. Metab. Disord. 23, 1327-1332
35. Irrcher, I., Adhihetty, P. J., Sheehan, T., Joseph, A. M., and Hood, D. A. (2003) PPARgamma coactivator-1alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations. Am. J. Physiol. 284, C1669-C1677
36. Wu, Z. D., Puigserver, P., Andersson, U., Zhang, C. Y., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124
37. Meirhaeghe, A., Crowley, V., Lenaghan, C., Lelliott, C., Green, K., Stewart, A., Hart, K., Schinner, S., Sethi, J. K., Yeo, G., et al. (2003) Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator- activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem. J. 373, 155-165
38. Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., and Kelly, D. P. (2000) Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106, 847-856
39. Czubryt, M. P., McAnally, J., Fishman, G. I., and Olson, E. N. (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA 100, 1711-1716
40. Russell, L. K., Mansfield, C. M., Lehman, J. J., Kovacs, A., Courtois, M., Saffitz, J. E., Medeiros, D. M., Valencik, M. L., McDonald, J. A., and Kelly, D. P. (2004) Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res. 94, 525-533
41. Goto, M., Terada, S., Kato, M., Katoh, M., Yokozeki, T., Tabata, I., and Shimokawa, T. (2000) cDNA Cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. Biochem. Biophys. Res. Commun. 274, 350-354
42. Gordon, J. W., Rungi, A. A., Inagaki, H., and Hood, D. A. (2001) Effects of contractile activity on mitochondrial transcription factor A expression in skeletal muscle. J. Appl. Physiol. 90, 389-396
43. Baar, K., Wende, A. R., Jones, T. E., Marison, M., Nolte, L. A., Chen, M., Kelly, D. P., and Holloszy, J. O. (2002) Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 16, 1879-1886
44. Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., et al. (2003) Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278, 17190-17197
45. Rossignol, R., Malgat, M., Mazat, J. P., and Letellier, T. (1999) Threshold effect and tissue specificity - implication for mitochondrial cytopathies. J. Biol. Chem. 274, 33426-33432
46. Yamaguchi, F., Kawana, K., Tanonaka, K., Kamano, I., Igarashi, T., Gen, E., Fujimoto, Y., Maki, T., Sanbe, A., Nasa, Y., et al. (1999) Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril. Br. J. Pharmacol. 126, 1585-1592
47. Vescovo, G., DallaLibera, L., Serafini, F., Leprotti, C., Facchin, L., Volterrani, M., Ceconi, C., and Ambrosio, G. B. (1998) Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation 98, 1742-1749
48. Drexler, H., Banhardt, U., Meinertz, T., Wollschlager, H., Lehmann, M., and Just, H. (1989) Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 79, 491-502